Table 3.
Variables | Study period | P for trend | ||||
---|---|---|---|---|---|---|
2005 (n=270) | 2006 (n=229) | 2007 (n=229) | 2008 (n=200) | 2009 (n=200) | ||
No with ischaemic stroke | 221 | 180 | 195 | 162 | 179 | — |
Thrombolysis | 6 /217 (2.8) | 13/173 (7.5) | 26/192 (13.5) | 32/159 (20.1) | 27/172 (15.7) | <0.001 |
Aspirin started at any time in acute phase* | 133/157 (84.7) | 140/175 (80.0) | 166/190 (87.4) | 136/156 (87.2) | 149/166 (89.8) | 0.10 |
Aspirin started by 48 hours after stroke |
109/147 (74.2) | 124/171 (72.5) | 149/186 (80.1) | 93/129 (72.1) | 80/102 (78.4) | 0.36 |
No with failed swallow screen† | 70 | 75 | 69 | 52 | 55 | 0.03 |
Fed by enteral route‡ | 28/69 (40.6) | 40/74 (54.1) | 39/68 (57.4) | 24/51 (47.1) | 33/50 (66.0) | |
Intravenous fluids† | 130/236 (55.1) | 123/203 (60.6) | 116/209 (55.5) | 115/180 (63.9) | 92/183 (50.3) | 0.64 |
No requiring physiotherapy or occupational therapy† | 213 | 181 | 196 | 157 | 158 | 0.61 |
Physiotherapy or occupational therapy received | 168/209 (80.4) | 155/181 (85.6) | 155/196 (79.1) | 126/148 (85.1) | 122/138 (88.4) | |
No requiring speech and language therapy† | 166 | 168 | 167 | 139 | 128 | 0.53 |
Speech and language therapy received | 96/161 (59.6) | 107/164 (65.2) | 105/166 (63.2) | 81/133 (60.9) | 67/101 (66.3) |
*Within first seven days of stroke.
†Analysis limited to patients admitted to hospital.
‡Nasogastric or percutaneous endoscopic gastrostomy.